An Iceland-based company, deCode Genetics, announced in February that it is offering a test for eight genetic variants related to prostate cancer.

Novel software that combines gene activity and tissue location to decode disease mechanisms Date: June 3, 2024 Source: University of Colorado Anschutz Medical Campus Summary: A new computational ...

News about deCODE Genetics, Incorporated, including commentary and archival articles published in The New York Times.

DeCode Genetics Inc. scientists mapped a gene linked to rheumatoid arthritis, a step that could aid development of medicines and diagnostic tests.